Chemed Corporation
CHE · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6,508 | $7,112 | $8,997 | $7,869 |
| - Cash | $130 | $250 | $174 | $178 |
| + Debt | $141 | $146 | $145 | $141 |
| Enterprise Value | $6,520 | $7,008 | $8,968 | $7,832 |
| Revenue | $625 | $619 | $647 | $640 |
| % Growth | 1% | -4.4% | 1.1% | – |
| Gross Profit | $181 | $185 | $216 | $234 |
| % Margin | 28.9% | 29.8% | 33.5% | 36.6% |
| EBITDA | $102 | $88 | $112 | $136 |
| % Margin | 16.3% | 14.2% | 17.3% | 21.3% |
| Net Income | $64 | $52 | $72 | $90 |
| % Margin | 10.3% | 8.5% | 11.1% | 14.1% |
| EPS Diluted | 4.46 | 3.57 | 4.86 | 6.02 |
| % Growth | 24.9% | -26.5% | -19.3% | – |
| Operating Cash Flow | $83 | $139 | $33 | $165 |
| Capital Expenditures | -$17 | -$16 | -$13 | -$13 |
| Free Cash Flow | $66 | $123 | $19 | $152 |